HRT Financial’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,171
| Closed | -$281K | – | 3251 |
|
|
2024
Q4 | $281K | Sell |
7,171
-22,470
| -76% | -$881K | ﹤0.01% | 1554 |
|
|
2024
Q3 | $1.17M | Sell |
29,641
-4,551
| -13% | -$179K | 0.01% | 1080 |
|
|
2024
Q2 | $1.33M | Buy |
34,192
+1,584
| +5% | +$61.8K | 0.01% | 829 |
|
|
2024
Q1 | $1.4M | Sell |
32,608
-50,461
| -61% | -$2.17M | 0.01% | 694 |
|
|
2023
Q4 | $3.83M | Buy |
83,069
+47,859
| +136% | +$2.2M | 0.03% | 374 |
|
|
2023
Q3 | $1.2M | Buy |
35,210
+17,264
| +96% | +$589K | 0.01% | 797 |
|
|
2023
Q2 | $690K | Buy |
+17,946
| New | +$690K | 0.01% | 1084 |
|
|
2022
Q4 | – | Sell |
-15,927
| Closed | -$574K | – | 3047 |
|
|
2022
Q3 | $574K | Sell |
15,927
-3,975
| -20% | -$143K | 0.01% | 1279 |
|
|
2022
Q2 | $605K | Buy |
+19,902
| New | +$605K | 0.01% | 1316 |
|
|
2021
Q4 | – | Sell |
-10,357
| Closed | -$158K | – | 3868 |
|
|
2021
Q3 | $158K | Sell |
10,357
-8,297
| -44% | -$127K | ﹤0.01% | 2502 |
|
|
2021
Q2 | $347K | Sell |
18,654
-2,224
| -11% | -$41.4K | ﹤0.01% | 1962 |
|
|
2021
Q1 | $373K | Buy |
+20,878
| New | +$373K | ﹤0.01% | 1786 |
|
|
2020
Q1 | – | Sell |
-18,220
| Closed | -$238K | – | 1320 |
|
|
2019
Q4 | $238K | Buy |
+18,220
| New | +$238K | 0.01% | 813 |
|